“It was first understood as our main defense against opioid overdose,” Nguyen said. “The issue is that for some time, the FDA had not granted the approval of over-the-counter, non-prescription use of Naloxone because I think the standards for treating opioid overdoses were still being developed.”
Trending
- Vardaman Scholars learn to impact world ‘beyond Baylor bubble’
- Baylor history students look forward to annual picnic celebration
- Learning independence: Baylor students navigate life beyond home
- Old Dominion set to bring multigenerational sound to Family Weekend
- Armstrong launches 2 HRs against former team in Baylor’s 6-2 win over UT Arlington
- Bears at large: Women’s tennis gets bid to NCAA Tournament
- PACCoffee brews Broadway into a cup
- Voting isn’t optional — it’s how we keep our country going

